跳至主要内容
临床试验/IRCT20141025019669N20
IRCT20141025019669N20尚未招募2 期

Survey the effect of oleoylethanolamide on fasting blood sugar level, insulin resistance, lipid profile, oxidative stress status, inflammatory factors, sex hormones levels and anti-Mullerian hormone in women with poly cystic ovarian syndrome

Qazvin University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 45 years(—)
性别
Female

入选标准

  • The patients who are 18-45 years old diagnosed with the poly cystic ovarian syndrome
  • Having at least two criteria from Rotterdam's three criteria to diagnose this syndrome;
  • BMI of less than 30
  • Signed consent by the patient

排除标准

  • Pregnancy; lactation and menopause;
  • Infectious disease; inflammatory disease; Cushing's syndrome; adrenal gland tumor; hypothyroidism; increased prolactinemia; acromegaly; diabetes and cancer;
  • Hormone therapy over the past three months;
  • Taking antioxidant supplements over the past three months,
  • Drug use over the past three months includes contraceptives; glucocorticoids; lipid-lowering drugs and weight loss drugs.

研究者

相似试验